As the world becomes more educated and advanced in molecular medicine, the healthcare industry is experiencing a growing convergence of therapeutics and diagnostics. Jean Luc Vanderheyden, Molecular Imaging Global Leader at GE Healthcare, explains how the Company is positioned at the forefront of this convergence with the latest in radiopharmacy and pre-clinical innovations. For more information, please visit http://newsroom.gehealthcare.com/
All Comments